Low-dose oral methotrexate for the management of childhood Cogan's syndrome: A case report

Clinical Rheumatology

Volumn 26, Issue 12, 2007, Pages 2201-2203

  Inoue, Yuzaburo ^a   Tomemori, Takuya ^a   Suzuki, Shuichi ^a   Arima, Takayasu ^a   Tomiita, Minako ^a   Shimojo, Naoki ^a   Kohno, Yoichi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Cogan's syndrome; Complements; Corticosteroid; Methotrexate

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CORTICOSTEROID DERIVATIVE; IBUPROFEN; METHOTREXATE; MOLECULAR MARKER; PREDNISOLONE;

ARTHRALGIA; ARTICLE; CASE REPORT; CHILDHOOD DISEASE; COGAN SYNDROME; DISEASE ACTIVITY; DISEASE MARKER; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EPISCLERITIS; ERYTHROCYTE SEDIMENTATION RATE; FEVER; HEARING TEST; HOSPITALIZATION; HUMAN; JAPANESE; JUVENILE RHEUMATOID ARTHRITIS; LEUKOCYTE COUNT; LOW DRUG DOSE; MALE; PERCEPTION DEAFNESS; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ADMINISTRATION, ORAL; CHILD; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HEARING LOSS, SENSORINEURAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATITIS; MALE; METHOTREXATE; SYNDROME;

EID: 36248947274     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0686-y     Document Type: Article

References (12)

1. Cogan D (1945) Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol 33:144-149
2. Haynes BF, Kaiser-Kupfer MI, Mason P et al (1980) Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine (Baltimore) 59:426-441
3. Grasland A, Pouchot J, Hachulla E et al (2004) Typical and atypical Cogan's syndrome: 32 cases and review of the literature. Rheumatology (Oxford) 43:1007-1015
4. Richardson B (1994) Methotrexate therapy for hearing loss in Cogan's syndrome. Arthritis Rheum 37:1559-1561
5. Vaiopoulos G, Sfikakis PP, Skoumas B et al (1994) Lack of response to corticosteroids and pulse cyclophosphamide therapy in Cogan's syndrome. Clin Rheumatol 13:110-112
6. Pouchot J, Vinceneux P, Bouccara D et al (1995) Methotrexate as a steroid-sparing agent in Cogan's syndrome: Comment on the concise communication by Richardson. Arthritis Rheum 38:1348-1349
7. Riente L, Taglione E, Berrettini S (1996) Efficacy of methotrexate in Cogan's syndrome. J Rheumatol 23:1830-1831
8. Covelli M, Lapadula G, Pipitone V (1999) Cogan's syndrome: Unsuccessful outcome with early combination therapy. Clin Exp Rheumatol 17:479-483
9. Singsen BH, Goldbach-Mansky R (1997) Methotrexate in the treatment of juvenile rheumatoid arthritis and other pediatric rheumatoid and nonrheumatic disorders. Rheum Dis Clin North Am 23:811-840
10. Ndiaye IC, Rassi SJ, Wiener-Vacher SR (2002) Cochleovestibular impairment in pediatric Cogan's syndrome. Pediatrics 109:E38
11. Martinez-Osorio H, Fuentes-Paez G, Calonge M (2006) Severe keratopathy in paediatric Cogan's syndrome. Rheumatology (Oxford) 45:1576-1577
12. Matteson EL, Fabry DA, Facer GW et al (2001) Open trial of methotrexate as treatment for autoimmune hearing loss. Arthritis Rheum 45:146-150